(-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1352766 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of KIF18A mRNA CTD PMID:22079256 1,1-dichloroethene increases expression ISO RGD:1319363 6480464 vinylidene chloride results in increased expression of KIF18A mRNA CTD PMID:26682919 1,2-dimethylhydrazine decreases expression ISO RGD:1319363 6480464 1, 2-Dimethylhydrazine results in decreased expression of KIF18A mRNA CTD PMID:22206623 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of KIF18A mRNA CTD PMID:30723492 17beta-estradiol increases expression ISO RGD:1352766 6480464 Estradiol results in increased expression of KIF18A mRNA CTD PMID:19167446 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of KIF18A mRNA CTD PMID:26372666 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:1319363 6480464 [2 more ... CTD PMID:25510870 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO RGD:1352766 6480464 2 more ... CTD PMID:31173147 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO RGD:1319363 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1319363 6480464 Tetrachlorodibenzodioxin results in decreased expression of KIF18A mRNA CTD PMID:19770486 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of KIF18A mRNA CTD PMID:32109520 , PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1319363 6480464 Tetrachlorodibenzodioxin affects the expression of KIF18A mRNA CTD PMID:21570461 2-butoxyethanol increases expression ISO RGD:1319363 6480464 n-butoxyethanol results in increased expression of KIF18A mRNA CTD PMID:19812364 3,4-methylenedioxymethamphetamine increases expression ISO RGD:1319363 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of KIF18A mRNA CTD PMID:20188158 3-methylcholanthrene increases expression ISO RGD:1319363 6480464 Methylcholanthrene results in increased expression of KIF18A mRNA CTD PMID:20713471 3-methylcholanthrene multiple interactions EXP 6480464 Methylcholanthrene inhibits the reaction [8-prenylnaringenin results in increased expression of KIF18A mRNA] CTD PMID:26372666 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of KIF18A mRNA CTD PMID:24780913 acetamide increases expression EXP 6480464 acetamide results in increased expression of KIF18A mRNA CTD PMID:31881176 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of KIF18A mRNA CTD PMID:28959563 acrylamide increases expression ISO RGD:1319363 6480464 Acrylamide results in increased expression of KIF18A mRNA CTD PMID:30807115 aflatoxin B1 affects expression ISO RGD:1352766 6480464 Aflatoxin B1 affects the expression of KIF18A protein CTD PMID:20106945 aflatoxin B1 decreases expression ISO RGD:1352766 6480464 Aflatoxin B1 results in decreased expression of KIF18A mRNA CTD PMID:32234424 aflatoxin B1 increases methylation ISO RGD:1352766 6480464 Aflatoxin B1 results in increased methylation of KIF18A gene CTD PMID:27153756 aflatoxin B1 decreases expression ISO RGD:1319363 6480464 Aflatoxin B1 results in decreased expression of KIF18A mRNA CTD PMID:19770486 all-trans-retinoic acid decreases expression ISO RGD:1352766 6480464 Tretinoin results in decreased expression of KIF18A mRNA CTD PMID:33167477 amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of KIF18A mRNA CTD PMID:30779732 arsenite(3-) multiple interactions ISO RGD:1352766 6480464 arsenite inhibits the reaction [G3BP1 protein binds to KIF18A mRNA] CTD PMID:32406909 azathioprine decreases expression ISO RGD:1352766 6480464 Azathioprine results in decreased expression of KIF18A mRNA CTD PMID:22623647 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1352766 6480464 7 more ... CTD PMID:19150397 , PMID:20382639 bis(2-ethylhexyl) phthalate decreases expression EXP 6480464 Diethylhexyl Phthalate results in decreased expression of KIF18A mRNA CTD PMID:20920545 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of KIF18A mRNA CTD PMID:25181051 , PMID:34947998 bisphenol A decreases expression ISO RGD:1352766 6480464 bisphenol A results in decreased expression of KIF18A mRNA CTD PMID:29275510 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of KIF18A mRNA CTD PMID:30816183 , PMID:32528016 bisphenol F increases expression ISO RGD:1319363 6480464 bisphenol F results in increased expression of KIF18A mRNA CTD PMID:30951980 buta-1,3-diene increases expression ISO RGD:1319363 6480464 1, 3-butadiene results in increased expression of KIF18A mRNA CTD PMID:29038090 cadmium atom multiple interactions ISO RGD:1352766 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of KIF18A mRNA CTD PMID:35301059 cadmium dichloride multiple interactions ISO RGD:1352766 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of KIF18A mRNA CTD PMID:35301059 caffeine decreases phosphorylation ISO RGD:1352766 6480464 Caffeine results in decreased phosphorylation of KIF18A protein CTD PMID:35688186 calcitriol decreases expression ISO RGD:1352766 6480464 Calcitriol results in decreased expression of KIF18A mRNA CTD PMID:21592394 calcitriol multiple interactions ISO RGD:1352766 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of KIF18A mRNA CTD PMID:21592394 cefaloridine decreases expression EXP 6480464 Cephaloridine results in decreased expression of KIF18A mRNA CTD PMID:18500788 choline multiple interactions ISO RGD:1319363 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of KIF18A mRNA CTD PMID:20938992 cisplatin decreases expression ISO RGD:1352766 6480464 Cisplatin results in decreased expression of KIF18A mRNA CTD PMID:27392435 cisplatin multiple interactions ISO RGD:1352766 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of KIF18A mRNA CTD PMID:27392435 cobalt dichloride decreases expression ISO RGD:1352766 6480464 cobaltous chloride results in decreased expression of KIF18A mRNA CTD PMID:19376846 copper(II) sulfate decreases expression ISO RGD:1352766 6480464 Copper Sulfate results in decreased expression of KIF18A mRNA CTD PMID:19549813 coumestrol multiple interactions ISO RGD:1352766 6480464 [Coumestrol co-treated with 2 more ... CTD PMID:18310284 , PMID:19167446 coumestrol increases expression ISO RGD:1352766 6480464 Coumestrol results in increased expression of KIF18A mRNA CTD PMID:19167446 CU-O LINKAGE decreases expression ISO RGD:1352766 6480464 cupric oxide results in decreased expression of KIF18A mRNA CTD PMID:22077320 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of KIF18A mRNA CTD PMID:26577399 cyclosporin A decreases expression ISO RGD:1319363 6480464 Cyclosporine results in decreased expression of KIF18A mRNA CTD PMID:19770486 cyclosporin A decreases expression ISO RGD:1352766 6480464 Cyclosporine results in decreased expression of KIF18A mRNA CTD PMID:20106945 , PMID:21632981 dicrotophos decreases expression ISO RGD:1352766 6480464 dicrotophos results in decreased expression of KIF18A mRNA CTD PMID:28302478 dorsomorphin multiple interactions ISO RGD:1352766 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KIF18A mRNA CTD PMID:27188386 doxorubicin decreases expression ISO RGD:1352766 6480464 Doxorubicin results in decreased expression of KIF18A mRNA CTD PMID:30031762 Enterolactone multiple interactions ISO RGD:1352766 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of KIF18A mRNA CTD PMID:19167446 ethanol multiple interactions ISO RGD:1319363 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of KIF18A mRNA CTD PMID:30517762 folic acid multiple interactions ISO RGD:1319363 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of KIF18A mRNA CTD PMID:20938992 furan increases expression EXP 6480464 furan results in increased expression of KIF18A mRNA CTD PMID:25539665 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of KIF18A mRNA CTD PMID:22061828 hydrogen peroxide affects expression ISO RGD:1352766 6480464 Hydrogen Peroxide affects the expression of KIF18A mRNA CTD PMID:20044591 hydroquinone decreases expression ISO RGD:1352766 6480464 hydroquinone results in decreased expression of KIF18A mRNA CTD PMID:23416264 L-methionine multiple interactions ISO RGD:1319363 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of KIF18A mRNA CTD PMID:20938992 lead(0) affects expression ISO RGD:1352766 6480464 Lead affects the expression of KIF18A mRNA CTD PMID:28903495 lead(2+) affects expression ISO RGD:1352766 6480464 Lead affects the expression of KIF18A mRNA CTD PMID:28903495 leflunomide decreases expression ISO RGD:1352766 6480464 leflunomide results in decreased expression of KIF18A mRNA CTD PMID:28988120 lidocaine increases expression EXP 6480464 Lidocaine results in increased expression of KIF18A mRNA CTD PMID:35283115 N-Nitrosopyrrolidine decreases expression ISO RGD:1352766 6480464 N-Nitrosopyrrolidine results in decreased expression of KIF18A mRNA CTD PMID:32234424 ochratoxin A decreases acetylation ISO RGD:1352766 6480464 ochratoxin A results in decreased acetylation of KIF18A promoter CTD PMID:29098329 ochratoxin A decreases expression ISO RGD:1352766 6480464 ochratoxin A results in decreased expression of KIF18A mRNA CTD PMID:29098329 ochratoxin A multiple interactions ISO RGD:1352766 6480464 [ochratoxin A results in decreased acetylation of KIF18A promoter] which results in decreased expression of KIF18A mRNA CTD PMID:29098329 oxaliplatin decreases expression EXP 6480464 oxaliplatin results in decreased expression of KIF18A mRNA CTD PMID:25729387 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of KIF18A mRNA CTD PMID:25729387 ozone multiple interactions ISO RGD:1319363 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of KIF18A mRNA, [Air Pollutants results in increased abundance of Ozone] which results in increased expression of KIF18A mRNA CTD PMID:34911549 paracetamol increases expression ISO RGD:1352766 6480464 Acetaminophen results in increased expression of KIF18A mRNA CTD PMID:22230336 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of KIF18A mRNA CTD PMID:33387578 PCB138 multiple interactions ISO RGD:1319363 6480464 [2 more ... CTD PMID:25510870 phenanthridone increases metabolic processing ISO RGD:1352766 6480464 phenanthridone results in increased metabolism of KIF18A protein CTD PMID:28209915 piroxicam decreases expression ISO RGD:1352766 6480464 Piroxicam results in decreased expression of KIF18A mRNA CTD PMID:21858171 potassium chromate multiple interactions ISO RGD:1352766 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of KIF18A mRNA CTD PMID:22079256 potassium chromate decreases expression ISO RGD:1352766 6480464 potassium chromate(VI) results in decreased expression of KIF18A mRNA CTD PMID:22079256 propanal decreases expression ISO RGD:1352766 6480464 propionaldehyde results in decreased expression of KIF18A mRNA CTD PMID:26079696 quercetin decreases expression ISO RGD:1352766 6480464 Quercetin results in decreased expression of KIF18A mRNA CTD PMID:21632981 resveratrol multiple interactions ISO RGD:1352766 6480464 [Coumestrol co-treated with resveratrol] results in increased expression of KIF18A mRNA CTD PMID:19167446 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of KIF18A mRNA CTD PMID:28374803 SB 431542 multiple interactions ISO RGD:1352766 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KIF18A mRNA CTD PMID:27188386 senecionine increases expression EXP 6480464 senecionine results in increased expression of KIF18A mRNA CTD PMID:32419051 silicon dioxide decreases expression ISO RGD:1319363 6480464 Silicon Dioxide results in decreased expression of KIF18A mRNA CTD PMID:19073995 , PMID:33720480 silver atom decreases expression ISO RGD:1319363 6480464 Silver results in decreased expression of KIF18A mRNA CTD PMID:27131904 silver(0) decreases expression ISO RGD:1319363 6480464 Silver results in decreased expression of KIF18A mRNA CTD PMID:27131904 sodium arsenite decreases expression ISO RGD:1319363 6480464 sodium arsenite results in decreased expression of KIF18A mRNA CTD PMID:17998272 sophoraflavanone B increases expression EXP 6480464 8-prenylnaringenin results in increased expression of KIF18A mRNA CTD PMID:26372666 sophoraflavanone B multiple interactions EXP 6480464 Methylcholanthrene inhibits the reaction [8-prenylnaringenin results in increased expression of KIF18A mRNA] CTD PMID:26372666 sulforaphane increases expression ISO RGD:1352766 6480464 sulforaphane results in increased expression of KIF18A mRNA CTD PMID:31838189 sunitinib decreases expression ISO RGD:1352766 6480464 Sunitinib results in decreased expression of KIF18A mRNA CTD PMID:31533062 testosterone multiple interactions ISO RGD:1352766 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of KIF18A mRNA CTD PMID:21592394 testosterone decreases expression ISO RGD:1352766 6480464 Testosterone results in decreased expression of KIF18A mRNA CTD PMID:21592394 tetrachloromethane multiple interactions ISO RGD:1319363 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of KIF18A mRNA CTD PMID:30517762 tetrachloromethane increases expression ISO RGD:1319363 6480464 Carbon Tetrachloride results in increased expression of KIF18A mRNA CTD PMID:31919559 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of KIF18A mRNA CTD PMID:25729387 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of KIF18A mRNA CTD PMID:25729387 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of KIF18A mRNA CTD PMID:33387578 trichostatin A decreases expression ISO RGD:1352766 6480464 trichostatin A results in decreased expression of KIF18A mRNA CTD PMID:26272509 trichostatin A multiple interactions ISO RGD:1352766 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KIF18A mRNA CTD PMID:27188386 triclosan decreases expression ISO RGD:1352766 6480464 Triclosan results in decreased expression of KIF18A mRNA CTD PMID:30510588 trimellitic anhydride increases expression ISO RGD:1319363 6480464 trimellitic anhydride results in increased expression of KIF18A mRNA CTD PMID:19042947 trovafloxacin decreases expression ISO RGD:1319363 6480464 trovafloxacin results in decreased expression of KIF18A mRNA CTD PMID:35537566 valproic acid decreases methylation ISO RGD:1352766 6480464 Valproic Acid results in decreased methylation of KIF18A gene CTD PMID:29154799 valproic acid decreases expression ISO RGD:1352766 6480464 Valproic Acid results in decreased expression of KIF18A mRNA CTD PMID:28001369